The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
SMAD4 gene mutation and prognosis of pancreatic adenocarcinoma.
Olfa Derbel
No relevant relationships to disclose
Arnaud de la Fouchardière
No relevant relationships to disclose
Julien Peron
No relevant relationships to disclose
Francoise Desseigne
No relevant relationships to disclose
Pierre Heudel
No relevant relationships to disclose
Pierre Guibert
No relevant relationships to disclose
Michel Rivoire
No relevant relationships to disclose
Pierre Meeus
No relevant relationships to disclose
Patrice Peyrat
No relevant relationships to disclose
Anne-Isabelle Lemaistre
No relevant relationships to disclose
Christelle De La Fouchardiere
No relevant relationships to disclose